Skip to content
← Back to this collection

PUBLICATIONS · 26304888

Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2015 Nov 10
First author
Feijen EA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Feijen EA
      type
      Author
    2. name
      Leisenring WM
      type
      Author
    3. name
      Stratton KL
      type
      Author
    4. name
      Ness KK
      type
      Author
    5. name
      van der Pal HJ
      type
      Author
    6. name
      Caron HN
      type
      Author
    7. name
      Armstrong GT
      type
      Author
    8. name
      Green DM
      type
      Author
    9. name
      Hudson MM
      type
      Author
    10. name
      Oeffinger KC
      type
      Author
    11. name
      Robison LL
      type
      Author
    12. name
      Stovall M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Feijen EA
      type
      Author
    2. name
      Leisenring WM
      type
      Author
    3. name
      Stratton KL
      type
      Author
    4. name
      Ness KK
      type
      Author
    5. name
      van der Pal HJ
      type
      Author
    6. name
      Caron HN
      type
      Author
    7. name
      Armstrong GT
      type
      Author
    8. name
      Green DM
      type
      Author
    9. name
      Hudson MM
      type
      Author
    10. name
      Oeffinger KC
      type
      Author
    11. name
      Robison LL
      type
      Author
    12. name
      Stovall M
      type
      Author
    bibliography ids
    1. nci-bib-3619f68050a5005465a58f11
    book metadata
    content sha256
    74355c565367d1a7b4167c1057a00584ab1a13dde12fe60c4f0bbdd284fa71f1
    document type
    citation
    dois
    1. 10.1200/JCO.2015.61.5187
    electronic publication date
    display
    2015 Aug 24
    precision
    day
    year
    2015
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26304888
    immutable id
    pubmed:26304888@74355c565367d1a7b4167c1057a00584ab1a13dde12fe60c4f0bbdd284fa71f1
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    32
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3774-80
    volume
    33
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26304888
      provenance
      batch id
      4c1ece5bfc3d8e2be622
      provider
      NCBI PubMed ESummary
      record sha256
      55bac281e31140f9fd7703531ef5afd11c91b9bdbd39f2b8926bf6260e17b63a
      response sha256
      85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
      retrieved at
      2026-09-09T23:47:12.730551+00:00
      publication date
      display
      2015 Nov 10
      precision
      day
      year
      2015
      publication types
      1. Comparative Study
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26304888/
      title
      Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.

      Preserved source evidence · Not medical advice